Specializes in the diagnosis and treatment of gastrointestinal tumors (gastric cancer, colorectal cancer, etc.) and onco‑cardiology, with extensive clinical experience in managing patients with both cancer and heart disease as well as anti‑tumor drug‑related cardiac toxicity. He has worked on the front‑line clinical practice for nearly two decades. As a principal investigator, he has led multiple clinical research projects and spearheaded and completed China’s first prospective interventional clinical study on immune checkpoint inhibitor‑associated myocarditis. He has published numerous academic papers, including more than 10 SCI papers in journals such as Nature Metabolism, Nature Communications and BMC Medicine. As the first author, he drafted the guideline *Clinical Practice Recommendations for the Diagnosis and Treatment of Immune Checkpoint Inhibitor‑Related Myocarditis*. He was awarded the Second Prize of the 2022 Shanghai Medical Science and Technology Award (2022021605).